noscript

News Hot Pursuit

 
Sun Pharma sails through the tide after strong Q1 results
13-Aug-19   16:35 Hrs IST

The result was announced during the market hours today, 13 August 2019.

Meanwhile, the S&P BSE Sensex tanked 623.75 points or 1.66% and closed at 36,958.16.

On the BSE, 9.04 lakh shares were traded in the counter so far compared with average daily volumes of 2.91 lakh shares in the past two weeks. The stock hit a high of Rs 444.8 and a low of Rs 420.8 so far during the day. The stock hit a 52-week high of Rs 678.8 on 06 Sep 2018. The stock hit a 52-week low of Rs 350.4 on 13 May 2019.

The company's earnings before interest tax depreciation and amortization (EBITDA) stood at Rs 1881 crore with an EBITDA margin of 22.8% in Q1 June 2019.

The company's R&D investments stood at Rs 422 crores (5.1% of sales) in Q1 June 2019 as compared to Rs. 500 crores (7% of sales) in Q1 June 2018.

Commenting on company's Q1 performance, Dilip Shanghvi, managing director of the company said, “We have recorded growth across most of the markets for the quarter and our performance is in-line with our full-year guidance. We are consistently focusing on improving our efficiencies and cost structure to ensure reasonable returns for our generics business. At the same time, we continue our unwavering efforts on building the specialty business and are encouraged by the potential of one of our pre-clinical research molecules which is likely to enter clinical trials next year.

Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company

Powered by Capital Market - Live News

Attention Investors:
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. Prevent Unauthorized Transactions in your Demat account\Trading account: Update your Mobile Number with your Depository Participant\Exchange. Receive alerts on your Registered Mobile for all debit and other important transactions in your Demat account\Trading account directly from Depository\Exchange on the same day.........issued in the interest of investors.
Disclosure of Proprietary Account Trading by Members to Clients
Proprietary Trading Disclosure:In terms of provisions of the Rules, Bye-Laws and Business Rules of the Exchange and with reference to circular MCX/T&S/147/2016 dated May 17, 2016 regarding Disclosure of Proprietary Account Trading by broker to client.,Pursuant to SEBI Circular Number SEBI/MRD/SEC/Cir-42/2003 dated November 19, 2003 & SEBI/HO/CDMRD/DMP/CIR/P/2016/49 dated April 25, 2016 GOODWILL WEALTH MANAGEMENT PVT LTD. Discloses to its clients about its policies on proprietary trades. Goodwill does proprietary trading in the derivatives segment at MCX respectively.GOODWILL – SEBI Reg No. INZ000049087
Copyright © 2016 All rights Reserved GOODWILL
Designed, Developed and content powered by CMOTS Infotech ( ISO 9001:2015 certified )
Filing complaints on SEBI Complaint Redress System (SCORES)
– Easy & quick
  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name, PAN, Address, Mobile Number, E-mail ID.
  • Benefits:
    • Effective communication
    • Speedy redressal of the grievances.
You can file complaints on SCORES through https://scores.gov.in/scores/Welcome.html